These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22467557)

  • 21. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems.
    Kreps GL; Villagran MM; Zhao X; McHorney CA; Ledford C; Weathers M; Keefe B
    Patient Educ Couns; 2011 Jun; 83(3):375-81. PubMed ID: 21602010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of motivational interviewing among hemodialysis clinic staff: a pilot study.
    Cronk NJ; Russell CL; Knowles N; Matteson M; Peace L; Ponferrada L
    Nephrol Nurs J; 2012; 39(5):385-91; quiz 392. PubMed ID: 23094340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
    Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivational interviewing to support antiretroviral therapy adherence: the role of quality counseling.
    Thrasher AD; Golin CE; Earp JA; Tien H; Porter C; Howie L
    Patient Educ Couns; 2006 Jul; 62(1):64-71. PubMed ID: 16023824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mental health clinicians' beliefs about medicines, attitudes, and expectations of improved medication adherence in patients.
    Byrne MK; Deane FP; Caputi P
    Eval Health Prof; 2008 Dec; 31(4):390-403. PubMed ID: 18826984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivational interviewing with hazardous drinkers.
    Beckham N
    J Am Acad Nurse Pract; 2007 Feb; 19(2):103-10. PubMed ID: 17300536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining what practising clinicians believe about long-acting injectable antipsychotic medication.
    Miles SW; Wheeler A; Davies K
    Int J Psychiatry Clin Pract; 2011 Jun; 15(2):135-44. PubMed ID: 22121862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of motivational interviewing into practice in the national exercise referral scheme in Wales: a mixed methods study.
    Moore GF; Moore L; Murphy S
    Behav Cogn Psychother; 2012 May; 40(3):313-30. PubMed ID: 22008506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influencing behaviour change in general practice - Part 2 - motivational interviewing approaches.
    Sim MG; Wain T; Khong E
    Aust Fam Physician; 2009 Dec; 38(12):986-9. PubMed ID: 20369152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychopharmocotherapy of schizophrenia in forensic and general psychiatry].
    Stompe T; Schanda H
    Neuropsychiatr; 2011; 25(2):75-84. PubMed ID: 21672506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivational interviewing for medication adherence.
    Salvo MC; Cannon-Breland ML
    J Am Pharm Assoc (2003); 2015; 55(4):e354-61; quiz e362-3. PubMed ID: 26161493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Compliance of long-acting atypical antipsychotics: from an image problem to a question of indication].
    Naudin J; Dassa D; Cermolacce M
    Encephale; 2009 Sep; 35(4):315-20. PubMed ID: 19748367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning motivational interviewing in a real-life setting: a randomised controlled trial in the Swedish Prison Service.
    Forsberg L; Ernst D; Farbring CÅ
    Crim Behav Ment Health; 2011 Jul; 21(3):177-88. PubMed ID: 21706526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark.
    Rubak S; Sandbaek A; Lauritzen T; Borch-Johnsen K; Christensen B
    Br J Gen Pract; 2006 Jun; 56(527):429-36. PubMed ID: 16762124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia.
    Arunpongpaisal S; Srisurapanont M; Kongsakon R; Kitiwattanagul K; Samanwongthai U
    J Med Assoc Thai; 2010 Mar; 93(3):343-50. PubMed ID: 20420110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adherence in the case of chronic diseases: patient-centred approach is needed].
    Klok T; Sulkers EJ; Kaptein AA; Duiverman EJ; Brand PL
    Ned Tijdschr Geneeskd; 2009; 153():A420. PubMed ID: 19900323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches for creating the therapeutic alliance: solution-focused interviewing, motivational interviewing, and the medication interest model.
    Cheng MK
    Psychiatr Clin North Am; 2007 Jun; 30(2):157-66. PubMed ID: 17643833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.
    Taylor D
    Br J Psychiatry Suppl; 2009 Nov; 52():S13-9. PubMed ID: 19880912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.